लोड हो रहा है...
Proteasome inhibitors – molecular basis and current perspectives in multiple myeloma
Inhibition of proteasome, a proteolytic complex responsible for the degradation of ubiquitinated proteins, has emerged as a powerful strategy for treatment of multiple myeloma (MM), a plasma cell malignancy. First-in-class agent, bortezomib, has demonstrated great positive therapeutic efficacy in MM...
में बचाया:
| में प्रकाशित: | J Cell Mol Med |
|---|---|
| मुख्य लेखकों: | , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
John Wiley & Sons, Ltd
2014
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4508135/ https://ncbi.nlm.nih.gov/pubmed/24712303 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.12279 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|